June 6, 2018

FDA: New labeling for liquid-filled intragastric balloons

By: Judy Mathias

Editor’s Note

The Food & Drug Administration on June 4 announced that it had approved new labeling on potential risks for liquid-filled intragastric balloons by Apollo Endosurgery and ReShape Lifesciences.

The new labeling for the Orbera and ReShape balloon systems includes more information about possible deaths linked to the use of these devices.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat